Cargando…
Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma
Rhabdomyosarcoma (RMS), a cancer characterized by features of skeletal muscle, is the most common soft‐tissue sarcoma of childhood. With 5‐year survival rates among high‐risk groups at < 30%, new therapeutics are desperately needed. Previously, using a myoblast‐based model of fusion‐negative RMS...
Autores principales: | Kovach, Alexander R., Oristian, Kristianne M., Kirsch, David G., Bentley, Rex C., Cheng, Changde, Chen, Xiang, Chen, Po‐Han, Chi, Jen‐Tsan Ashley, Linardic, Corinne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580881/ https://www.ncbi.nlm.nih.gov/pubmed/36037042 http://dx.doi.org/10.1002/1878-0261.13304 |
Ejemplares similares
-
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
por: Slemmons, Katherine K., et al.
Publicado: (2015) -
A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling
por: Slemmons, Katherine K., et al.
Publicado: (2021) -
Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence
por: Li, Jenny J., et al.
Publicado: (2021) -
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
por: Shields, Cara E., et al.
Publicado: (2021) -
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023)